Myriad Genetics Inc (NASDAQ:MYGN) has 213 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 31 Mar, 2026 | 125,000,000 | 125,000,000 | 0.00% | $122,875,000.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 15,303,850 | 424,423 | 2.85% | $94,118,678.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 8,889,644 | -6,414,206 | -41.91% | $40,003,403.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 8,225,371 | 342,856 | 4.35% | $50,586,032.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 6,700,158 | 1,951,831 | 41.11% | $41,205,972.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 6,668,817 | -31,341 | -0.47% | $30,009,676.00 |
| State Street Corp | 31 Mar, 2026 | 5,966,567 | 990,075 | 19.90% | $36,694,387.00 |
| GLENVIEW CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 5,411,978 | 824,571 | 17.97% | $24,353,901.00 |
| GLENVIEW CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 4,587,407 | 0 | 0.00% | $28,212,553.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 4,505,193 | -53,943 | -1.18% | $27,706,937.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 4,499,724 | -5,469 | -0.12% | $20,248,758.00 |
| State Street Corp | 31 Mar, 2026 | 4,424,027 | -1,542,540 | -25.85% | $19,908,122.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 4,320,564 | 2,168,785 | 100.79% | $26,571,468.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,924,525 | 3,924,525 | 0.00% | $17,660,363.00 |
| Morgan Stanley | 31 Mar, 2026 | 3,607,789 | -9,136 | -0.25% | $22,187,902.00 |
| Morgan Stanley | 31 Mar, 2026 | 3,168,742 | -439,047 | -12.17% | $14,259,341.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 2,582,231 | 2,582,231 | 0.00% | $11,620,040.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 2,366,092 | -1,954,472 | -45.24% | $10,647,414.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,319,379 | 88,087 | 3.95% | $10,439,417.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Mar, 2026 | 2,308,589 | 1,322,441 | 134.10% | $10,378.00 |